Evidence map›Paper›PMID 27032000›Full record

ArticleMicrobial drug resistance (Larchmont, N.Y.)2016

Emergence of Klebsiella pneumoniae ST273 Carrying bla

Andrew Chou, Marylette Roa, Michael A Evangelista, Arielle Kae Sulit, Evelina Lagamayo, Brian C Torres, David C Klinzing, Maria Luisa G Daroy, Josephine Navoa-Ng, Richard Sucgang and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Microbial drug resistance (Larchmont, N.Y.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Draft genome sequences of selectedMicrobiology resource announcements · 2025
    Article
  3. Article
  4. First report ofFrontiers in microbiology · 2022
    Article
  5. Review
  6. Genome Sequencing Identifies Previously Unrecognized Klebsiella pneumoniae Outbreaks in Neonatal Intensive Care Units in the Philippines.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  7. Article
  8. Article
  9. Characterization of the IncX3 Plasmid ProducingFrontiers in microbiology · 2020
    Article
  10. Review
  11. Article
  12. Phenotypic and molecular characterization ofNew microbes and new infections · 2018
    Article
  13. Simultaneous three Enterobacteriaceae with differentInfection and drug resistance · 2018
    Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Andrew Chou1 Division of Infectious Diseases, Department of Medicine, Baylor College of Medicine , Houston, Texas.
Marylette Roa3 Research and Biotechnology Group, St. Luke's Medical Center , Quezon City, Philippines .
Michael A Evangelista4 Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine , Houston, Texas.
Arielle Kae Sulit3 Research and Biotechnology Group, St. Luke's Medical Center , Quezon City, Philippines .
Evelina Lagamayo5 Pathology Institute, St. Luke's Medical Center , Quezon City, Philippines .
Brian C Torres3 Research and Biotechnology Group, St. Luke's Medical Center , Quezon City, Philippines .
David C Klinzing3 Research and Biotechnology Group, St. Luke's Medical Center , Quezon City, Philippines .
Maria Luisa G Daroy3 Research and Biotechnology Group, St. Luke's Medical Center , Quezon City, Philippines .
Josephine Navoa-Ng5 Pathology Institute, St. Luke's Medical Center , Quezon City, Philippines .
Richard Sucgang4 Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine , Houston, Texas.
Lynn Zechiedrich2 Department of Molecular Virology and Microbiology, Baylor College of Medicine , Houston, Texas.
St. Luke's Medical Center · PHBaylor College of Medicine · USSierra Nevada College · US

Funding

Research Training in Infections and ImmunityT32AI055413 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI GIORDANO, THOMAS P, MYSOREKAR, INDIRA U · 2003 to 2024
$3.2M
S2: Molecular Mechanisms Underlying Fluoroquinolone Susceptibility and ResistanceR01GM115501 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI ZECHIEDRICH, LYNN · 2015 to 2018
$1.7M
NIAID NIH HHS T32 AI055413NIGMS NIH HHS R01 GM115501
6 · The paper itself

Abstract

We sought to determine the epidemiology of carbapenem-resistant Enterobacteriaceae and to investigate the emergence of carbapenem-resistant Klebsiella pneumoniae in two teaching hospitals in Manila, Philippines. We screened 364 Enterobacteriaceae for carbapenem resistance between 2012 and 2013 and detected four carbapenem-resistant K. pneumoniae isolates from three different patients. We used whole genome sequencing to determine the antibiotic resistance profiles and confirmed the presence of carbapenemase genes by multiplex PCR. We used multilocus sequence typing and PCR-based replicon typing to genetically characterize the carbapenem-resistant isolates. The carbapenemase gene bla

Indexed as

AgedAged, 80 and overAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamasesbeta-Lactam ResistanceCarbapenemsFemaleGene ExpressionGenotypeHospitalsHumansKlebsiella InfectionsKlebsiella pneumoniaeMaleMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemscarbapenemasecarbapenem resistantEnterobacteriaceaemetallo-beta-lactamasemolecular epidemiologywhole genome sequencing

Identifiers

PMID27032000
PMCPMC5073224
OpenAlexW2319391774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.